Series B funding round for LEXEO Therapeutics raising $100M in September 2021
Series B funding round for LEXEO Therapeutics raising $100M in September 2021
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$280M
Top Valuation
-
LEXEO Therapeutics raised $100M in a Series B round.
The round was announced on 09/01/21.
The round was led by Daniel Saul Sundheim, Joy Ghosh.